The Effects of Mindfulness-based Interventions on Symptoms of Depression, Anxiety, and Cancer-related Fatigue in Oncology Patients: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Jul 14

PMID 35834503

Authors

Ellentika Chayadi

Naomi Baes

Litza Kiropoulos

Affiliations

Soon will be listed here.

Abstract

Objective: Mindfulness-based interventions (MBIs) are increasingly being integrated into oncological treatment to mitigate psychological distress and promote emotional and physical well-being. This review aims to provide the most recent evaluation of Mindfulness-Based Stress Reduction (MBSR), Mindfulness-Based Cognitive Therapy (MBCT), and Mindfulness-Based Cancer Recovery (MBCR) treatments, in reducing symptoms of depression, anxiety and CRF in oncology populations.

Methods: A search using the following search terms was conducted: (mindful* OR mindfulness* OR mindfulness-based* OR MBI* OR MBCT OR MBSR OR MBCR) AND (Oncol* OR cancer OR neoplasm OR lymphoma OR carcinoma OR sarcoma) to obtain relevant publications from five databases: PsycINFO, PubMed, Embase, and MEDLINE by EC, and ProQuest Dissertations & Theses Global from January 2000 to February 2022. 36 independent studies (n = 1677) were evaluated for their overall effect sizes (using random-effects models), subgroup analyses, and quality appraisals. Evaluations were performed separately for non-randomized (K = 20, n = 784) and randomized controlled trials (K = 16, n = 893).

Results: The results showed that MBIs have significant medium effects in reducing symptoms of depression (Hedges' g = 0.43), anxiety (Hedges' g = 0.55) and CRF (Hedges' g = 0.43), which were maintained at least three months post-intervention. MBIs were also superior in reducing symptoms of anxiety (Hedges' g = 0.56), depression (Hedges' g = 0.43), and CRF (Hedges' g = 0.42) in oncology samples relative to control groups. The superiority of MBIs to control groups was also maintained at least three months post-intervention for anxiety and CRF symptoms, but not for depressive symptoms. The risk of bias of the included studies were low to moderate.

Conclusions: This review found that MBIs reduced symptoms of depression, anxiety and CRF in oncology populations.

Systematic Review Registration: PROSPERO: International Prospective Register of Systematic Reviews: CRD42020143286.

Citing Articles

Prevalence and factors of meditation and yoga practice in the USA: How cancer and anxiety correlate.

Dunsmore V, Waters A, Reeder-Hayes K, Wheeler S Support Care Cancer. 2025; 33(3):191.

PMID: 39945998 PMC: 11825530. DOI: 10.1007/s00520-025-09231-0.

Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression.

Liu J, Guo Y, Lu Y, Wang B World J Psychiatry. 2025; 15(1):98737.

PMID: 39831015 PMC: 11684209. DOI: 10.5498/wjp.v15.i1.98737.

Does Personality Influence the Quality of Life of Patients with Brain Tumors Treated with Radiotherapy?.

Pilarska A, Pieczynska A, Adamska K, Hojan K Cancers (Basel). 2025; 17(1.

PMID: 39796758 PMC: 11719694. DOI: 10.3390/cancers17010131.

Exploring the Effects of Variety and Amount of Mindfulness Practices on Depression, Anxiety, and Stress Symptoms: Longitudinal Study on a Mental Health-Focused eHealth System for Patients With Breast or Prostate Cancer.

Malandrone F, Urru S, Berchialla P, Rossini P, Oliva F, Bianchi S JMIR Ment Health. 2024; 11:e57415.

PMID: 39571140 PMC: 11604212. DOI: 10.2196/57415.

Analysis of independent risk factors for postpartum depression in elderly primiparas and the effects of mindfulness-based psychological intervention.

Wu B, Wang N, Hu L, Wu G Am J Transl Res. 2024; 16(10):6130-6139.

PMID: 39544804 PMC: 11558359. DOI: 10.62347/YEMU2258.

References

McHugh M . Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012; 22(3):276-82. PMC: 3900052. View

Cella D, Davis K, Breitbart W, Curt G . Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001; 19(14):3385-91. DOI: 10.1200/JCO.2001.19.14.3385. View

Bower J . Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11(10):597-609. PMC: 4664449. DOI: 10.1038/nrclinonc.2014.127. View

Witek Janusek L, Tell D, Mathews H . Mindfulness based stress reduction provides psychological benefit and restores immune function of women newly diagnosed with breast cancer: A randomized trial with active control. Brain Behav Immun. 2019; 80:358-373. DOI: 10.1016/j.bbi.2019.04.012. View

Hofmann S, Sawyer A, Witt A, Oh D . The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010; 78(2):169-83. PMC: 2848393. DOI: 10.1037/a0018555. View

Bower J, Ganz P, Desmond K, Bernaards C, Rowland J, Meyerowitz B . Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006; 106(4):751-8. DOI: 10.1002/cncr.21671. View

Berger A, Mooney K, Alvarez-Perez A, Breitbart W, Carpenter K, Cella D . Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015; 13(8):1012-39. PMC: 5499710. DOI: 10.6004/jnccn.2015.0122. View

Park S, Sado M, Fujisawa D, Sato Y, Takeuchi M, Ninomiya A . Mindfulness-based cognitive therapy for Japanese breast cancer patients-a feasibility study. Jpn J Clin Oncol. 2017; 48(1):68-74. DOI: 10.1093/jjco/hyx156. View

Shennan C, Payne S, Fenlon D . What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psychooncology. 2010; 20(7):681-97. DOI: 10.1002/pon.1819. View

10.

Carlson L . Mindfulness-based interventions for coping with cancer. Ann N Y Acad Sci. 2016; 1373(1):5-12. DOI: 10.1111/nyas.13029. View

11.

Lengacher C, Shelton M, Reich R, Barta M, Johnson-Mallard V, Moscoso M . Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2012; 37(2):185-95. PMC: 3627743. DOI: 10.1007/s10865-012-9473-6. View

12.

Lee C, Kim S, Kim S, Joo H, Lee S . Effects of a Mindfulness-Based Stress Reduction Program on the Physical and Psychological Status and Quality of Life in Patients With Metastatic Breast Cancer. Holist Nurs Pract. 2017; 31(4):260-269. DOI: 10.1097/HNP.0000000000000220. View

13.

Spiegel D, Giese-Davis J . Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54(3):269-82. DOI: 10.1016/s0006-3223(03)00566-3. View

14.

Eyles C, Leydon G, Hoffman C, Copson E, Prescott P, Chorozoglou M . Mindfulness for the self-management of fatigue, anxiety, and depression in women with metastatic breast cancer: a mixed methods feasibility study. Integr Cancer Ther. 2014; 14(1):42-56. PMC: 4390604. DOI: 10.1177/1534735414546567. View

15.

Dobkin P . Mindfulness-based stress reduction: what processes are at work?. Complement Ther Clin Pract. 2008; 14(1):8-16. DOI: 10.1016/j.ctcp.2007.09.004. View

16.

Rush S, Sharma M . Mindfulness-Based Stress Reduction as a Stress Management Intervention for Cancer Care: A Systematic Review. J Evid Based Complementary Altern Med. 2016; 22(2):348-360. PMC: 5871193. DOI: 10.1177/2156587216661467. View

17.

Hoffman C, Ersser S, Hopkinson J, Nicholls P, Harrington J, Thomas P . Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol. 2012; 30(12):1335-42. DOI: 10.1200/JCO.2010.34.0331. View

18.

Pouy S, Peikani F, Nourmohammadi H, Sanei P, Tarjoman A, Borji M . Investigating the Effect of Mindfulness-Based Training on Psychological Status and Quality of Life in Patients with Breast Cancer. Asian Pac J Cancer Prev. 2018; 19(7):1993-1998. PMC: 6165667. DOI: 10.22034/APJCP.2018.19.7.1993. View

19.

Hoffman K, McCarthy E, Recklitis C, Ng A . Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009; 169(14):1274-81. DOI: 10.1001/archinternmed.2009.179. View

20.

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View